Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancer

Autor: Rasmussen, Line J.H., Schultz, Martin, Iversen, Kasper, Eugen-Olsen, Jesper, Helms, Morten, David, Kim, Kjaer, Andreas, Lebech, Anne-Mette, Kronborg, Gitte
Zdroj: In Clinical Biochemistry October 2020 84:31-37
Databáze: ScienceDirect